Pegintron Induction Therapy in HCV Non-Responders

NCT00363259 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Peginterferon alfa-2b
DRUG: Ribavirin

Sponsor

Foundation for Liver Research